Amphetamines are regarded to be metabolized, to some degree, by cytochrome P450 2D6 (CYP2D6) and Show small inhibition of CYP2D6 metabolism; potential for just a pharmacokinetic interaction exists with coadministration of CYP2D6 inhibitors which can maximize hazard with increased exposure to ampheta